Ineffectiveness of infliximab therapy in severe infantile Crohn's disease
Keywords: اینفیلیکسیماب; Crohn's disease; Infancy; Treatment; Infliximab;
مقالات ISI اینفیلیکسیماب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Rectal non-Hodgkin's lymphoma in an infliximab treated patient with ulcerative colitis and primary sclerosing cholangitis
Keywords: اینفیلیکسیماب; Infliximab; Ulcerative colitis; Non-Hodgkin's lymphoma; Primary sclerosing cholangitis;
Infliximab administered with shortened infusion times in a specialized IBD infusion unit: A prospective cohort study
Keywords: اینفیلیکسیماب; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Medical therapy; Infliximab; Infusion reactions;
Maintien de la réponse clinique au traitement par infliximab au cours de la spondylarthrite ankylosante : suivi à six ans
Keywords: اینفیلیکسیماب; Spondylarthrite ankylosante; Agents anti-TNFα; Infliximab; BASDAI; ASAS
Maintained clinical response of infliximab treatment in ankylosing spondylitis: A 6-year long-term study
Keywords: اینفیلیکسیماب; Ankylosing spondylitis; Anti-TNF-α agents; Infliximab; BASDAI; ASAS;
Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review
Keywords: اینفیلیکسیماب; Adalimumab; Immunosuppression; Infliximab; Pentostatin; Thiopurines; Tumor necrosis factor
Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis
Keywords: اینفیلیکسیماب; Nocardia farcinica; Anti-TNF; Psoriasis; Infliximab; Alefacept; Brain abscess
Efficacité de l'infliximab dans le traitement d'une triade d'occlusion folliculaire
Keywords: اینفیلیکسیماب; Triade d'occlusion folliculaire; Cellulite disséquante; Hidrosadénite suppurée; Spondylarthrite; Infliximab; Follicular occlusion triad; Dissecting cellulitis; Hidradenitis suppurativa; Spondyloarthritis; Infliximab;
Neuroprotective effects of infliximab in experimental spinal cord ischemic injury
Keywords: اینفیلیکسیماب; Antioxidants; Infliximab; Ischemia; Oxidative stress; Reperfusion injury; Spinal cord
Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis
Keywords: اینفیلیکسیماب; Rheumatoid arthritis; Cytokine; Interleukin-6 (IL-6); Interferon-γ (IFN-γ); Health Assessment Questionnaire (HAQ); Standard 28-joint Disease Activity Score (DAS28); DMARD; Infliximab; Etanercept; Adalimumab
Estudio comparativo de efectividad de los inhibidores del factor de necrosis tumoral alfa en la artritis reumatoide establecida
Keywords: اینفیلیکسیماب; Artritis reumatoide; Inhibidores del factor de necrosis tumoral alfa; Adalimumab; Disease Activity Score 28; Efectividad; Etanercept; Health Assessment Questionnaire; Infliximab; Rheumatoid arthritis; Tumour necrosis factor alpha antagonists; Adalimumab;
Réponse et tolérance aux anti-TNF des 475 premiers patients (polyarthrites rhumatoïdes ou spondylarthrites) traités par un même praticien, selon la capacité de ceux-ci à participer ou non aux études pivots
Keywords: اینفیلیکسیماب; Polyarthrite rhumatoïde; Spondylarthrite ankylosante; Spondylarthropathies; Anti-TNF; Infliximab; Étanercept; Adalimumab; Éligibilité; Recommandations; Études; Pratique quotidienne; Vraie-vie; Efficacité; Réponse; Toxicité; Effets indésirables; Décès
Outcome and safety of TNFα antagonist therapy in 475 consecutive outpatients (with rheumatoid arthritis or spondyloarthropathies) treated by a single physician according to their eligibility for clinical trials
Keywords: اینفیلیکسیماب; Rheumatoid arthritis; Ankylosing spondylitis; Spondyloarthropathies; TNFα antagonists; Infliximab; Etanercept; Adalimumab; Eligibility; Trials; Recommendations; Daily practice; Real life; Effectiveness; Outcome; Toxicity; Side effects; Death;
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
Keywords: اینفیلیکسیماب; Double-blind trial; Infliximab; Cancer-associated weight loss; Elderly patients; Non-small cell lung cancer
The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
Keywords: اینفیلیکسیماب; rheumatoid arthritis; influenza vaccine; infliximab; ankylosing spondylitis
Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis
Keywords: اینفیلیکسیماب; Osteoarthritis; Rheumatoid arthritis; TNF-α inhibitor; Infliximab; Inflammation
Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure
Keywords: اینفیلیکسیماب; CR; Complete response; PR; Partial response; MRI; Magnetic resonance imaging; PDAI; Perianal disease activity index; CD; Crohn's disease; EUS; Endosonography; EUA; Exploration under anaesthesia; CDAI; Crohn's disease activity index.; Perianal Crohn's dise
Sarcoidosis Appearing During Anti-Tumor Necrosis Factor α Therapy: A New “Class Effect” Paradoxical Phenomenon. Two Case Reports and Literature Review
Keywords: اینفیلیکسیماب; sarcoidosis; infliximab; adalimumab; TNF-α
Infections opportunistes non tuberculeuses au cours des traitements par les anti-TNFα
Keywords: اینفیلیکسیماب; Anti-TNFα; Infliximab; Étanercept; Adalimumab; Infections opportunistes; Mortalité; PréventionAnti-TNFα; Infliximab; Etanercept; Adalimumab; Opportunistic infections; Mortality; Prophylaxis
TNF-α inhibitors in asthma and COPD: We must not throw the baby out with the bath water
Keywords: اینفیلیکسیماب; Asthma; COPD; TNF-α; Etanercept; Infliximab; Golimumab
Pyoderma gangrenosum: A review and update on new therapies
Keywords: اینفیلیکسیماب; adalimumab; alefacept; clinical trials; efalizumab; etanercept; infliximab
Postoperative Management of Crohn Disease
Keywords: اینفیلیکسیماب; Crohn disease; Postoperative; Prevention; 5-ASA; Immunomodulators; Infliximab;
Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
Keywords: اینفیلیکسیماب; Crohn's Disease; Postoperative Recurrence; Prevention; Infliximab; bw; body weight; CRP; C-reactive protein; ESR; erythrocyte sedimentation rate; FC; fecal calprotectin; TNF; tumor necrosis factor;
Interleukin-15 and Its Soluble Receptor Mediate the Response to Infliximab in Patients With Crohn's Disease
Keywords: اینفیلیکسیماب; Interleukin-15 Receptor Alpha Subunit; Crohn's Disease; Infliximab; Epithelial CellCRP, C-reactive protein; IFX, infliximab; IL, interleukin; sIL-15R, secreted form of the interleukin-15 receptor; tm, transmembrane; SD, standard deviation; TNF, tumor necr
¿Es necesario asociar inmunomoduladores al tratamiento biológico en la enfermedad inflamatoria intestinal?
Keywords: اینفیلیکسیماب; Biológicos; Enfermedad inflamatoria intestinal; Inmunosupresores; Tratamiento combinado; Azatioprina; Infliximab; Adalimumab; Mercaptopurina; SeguridadBiological agents; Inflammatory bowel disease; Immunosuppressants; Combined therapy; Azathioprine; Infli
Listeria endocarditis in a patient with psoriatic arthritis on infliximab: Are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?
Keywords: اینفیلیکسیماب; Listeria; Infliximab; Endocarditis
Pulmonary Infectious Complications of Tumor Necrosis Factor Blockade
Keywords: اینفیلیکسیماب; Tumor necrosis factor; Infection; Tuberculosis; Granuloma; Etanercept; Infliximab; Adalimumab; Mechanism of action;
Review ArticleHepatosplenic T-cell lymphoma and inflammatory bowel disease
Keywords: اینفیلیکسیماب; Hepatosplenic T-cell lymphoma; Lymphoma; Infliximab; 6-Mercaptopurine; Inflammatory bowel disease;
Special ArticleReport of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
Keywords: اینفیلیکسیماب; mAbs; monoclonal antibodies; IFX; infliximab; ADA; adalimumab; CZP; Certolizumab pegol; PNR; primary non response to anti-TNF agent; LOR; loss of response to anti-TNF agent; ATI; antibodies to infliximab; ATA; antibodies to adalimumab; FcγR; Fc gamma rec
Marcadores de evolución de la enfermedad inflamatoria intestinal tratada con inmunomoduladores o agentes biológicos
Keywords: اینفیلیکسیماب; Enfermedad de Crohn; Colitis ulcerosa; Azatioprina; Infliximab; AdalimumabCrohn's disease; Ulcerative colitis; Azathioprine; Infliximab; Adalimumab
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
Keywords: اینفیلیکسیماب; hidradenitis suppurativa; infliximab; tumor necrosis factorAE, adverse event; CD, Crohn disease; CRP, C-reactive protein; DLQI, Dermatology Life Quality Index; ESR, erythrocyte sedimentation rate; HS, hidradenitis suppurativa; HSSI, Hidradenitis Suppurati
Tumor Necrosis Factor-α Monoclonal Antibodies in the Treatment of Inflammatory Bowel Disease: Clinical Practice Pharmacology
Keywords: اینفیلیکسیماب; Tumor necrosis factor-α; Infliximab; Adalimumab; Certolizumab pegol; Crohn disease; Ulcerative colitis;
Inflammatory bowel disease and hepatitis B and C in Western Balkans: A referral centre study and review of the literature
Keywords: اینفیلیکسیماب; Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Hepatitis B; Hepatitis C; Infliximab;
Innovative Uses of Tumor Necrosis Factor α Inhibitors
Keywords: اینفیلیکسیماب; Biologic; Etanrcept; Infliximab; Adalimumab; Skin; Off-label;
Pregnancy and Inflammatory Bowel Disease
Keywords: اینفیلیکسیماب; Crohn disease; Ulcerative colitis; Inflammatory bowel disease; Pregnancy; Infliximab;
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
Keywords: اینفیلیکسیماب; Crohn's disease; Mesalazine; Steroids; Budesonide; Azathioprine; Infliximab; Adalimumab; Surgery;
Review ArticleA decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
Keywords: اینفیلیکسیماب; Infliximab; Crohn's disease; Ulcerative colitis; IBD; Safety; Consensus;
Ten years of infliximab (Remicade®) in clinical practice: The story from bench to bedside
Keywords: اینفیلیکسیماب; Infliximab; Tumor necrosis factor; Monoclonal antibody; Inflammatory bowel disease; Rheumatoid arthritis
Psoriasis secundaria al tratamiento con infliximab y adalimumab en la enfermedad de Crohn
Keywords: اینفیلیکسیماب; Infliximab; Adalimumab; Psoriasis; Enfermedad inflamatoria intestinalInfliximab; Adalimumab; Flexural psoriasis; Inflammatory bowel disease
Ten years of infliximab: Insights from clinical trials in rheumatoid arthritis
Keywords: اینفیلیکسیماب; Infliximab; Tumor necrosis factor (TNF); Rheumatoid arthritis; Clinical trial
Infliximab for treating axial spondylarthropathy in everyday practice
Keywords: اینفیلیکسیماب; Spondylarthropathy; Ankylosing spondylitis; TNF antagonists; Infliximab
Thrombocytopenia associated with the use of anti–tumor necrosis factor–α agents for psoriasis
Keywords: اینفیلیکسیماب; adalimumab; efalizumab; etanercept; infliximab; psoriasis; thrombocytopenia
Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells
Keywords: اینفیلیکسیماب; Infliximab; Anti-TNF-α antibody; Rheumatoid arthritis; DNA microarray; Biomarker; Gene expression; Transcriptome; C-reactive protein; Methotrexate; Peripheral blood RNA
Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis
Keywords: اینفیلیکسیماب; Sarcoidosis; Neurosarcoidosis; Tumor necrosis factor; Infliximab; Cyclophosphamide; Central nervous systemAzathioprine, AZA; Central nervous system, CNS; Corticosteroids, CS; Magnetic resonance imaging, MRI; Methotrexate, MTX; Tumor necrosis factor α, TNF
Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease
Keywords: اینفیلیکسیماب; Infliximab; Steroid-refractory; Acute graft-versus-host disease
Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis
Keywords: اینفیلیکسیماب; Rheumatoid arthritis; Infliximab; Anti-CCP; Rheumatoid factor; Antinuclear antibodies
Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitis
Keywords: اینفیلیکسیماب; Infliximab; Steroid-dependent; Ulcerative colitis; Mucosal healing; Maintenance treatment;
Ten years of infliximab: Its role in dermatology
Keywords: اینفیلیکسیماب; Infliximab; Tumor necrosis factor (TNF); Psoriasis; Psoriasis severity and activity index (PASI); Safety
Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature
Keywords: اینفیلیکسیماب; Pregnancy; Infliximab; Etanercept; Adalimumab; VACTERL
Perception of improved state of health and subjective quality of life in Crohn's disease patients treated with Infliximab
Keywords: اینفیلیکسیماب; Crohn's disease; Depressive mood; Activity of CD; Subjective quality of life; Infliximab